Brighter postpones release of its year-end report to March 31 2015.

Brighter postpones release of its year-end report to March 31 2015.

    

About Brighter AB (publ).
By means of its intellectual property Brighter develops innovations for people who live with a medical condition. We develop the tools that improve the situation and every day lives of individuals. Half of Sweden’s 4.6 million households will be “connected” for home care or through mobile units within five years. Brighter’s objective is to simplify, streamline and strengthen the relationship between patients and healthcare professionals through the development of innovations in the area of digital health - a market that already today - 2015 - is valued at 160 Billion US dollars on a global basis.

The Company's shares are listed on NASDAQOMX First North/BRIG .
Visit our website and subscribe to press releases:
www.brighter.se

Certified Adviser
Brighter’s Certified Adviser on Nasdaq OMX First North is Remium Nordic AB, Per Grundström +46 (0)8 – 454 32 29, CorporateFinance@remium.com , www.remium.com .

For further information, please contact:

Henrik Norström, COO
Telephone: +46 733 40 30 45
Email: henrik.norstrom@brighter.se
Truls Sjöstedt, VD
Telephone : +46 709 73 46 00
Email: truls.sjostedt@brighter.se

Tags:

About Us

Brighter develops solutions for data-driven and mobile health services. Through its intellectual property and its first innovative tool Actiste®, the company creates a more efficient care chain with focus on the individual. Brighter is initially focused on diabetes care, but there are opportunities in the future to operate on a broader level, spanning more diseases and treatment approaches. This is done through The Benefit Loop®, Brighter’s cloud-based service that continuously collects, analyzes and shares data on the user's terms.

Subscribe

Documents & Links